<html><head><meta content="text/html; charset=UTF-8" http-equiv="content-type"><style type="text/css">@import url(https://themes.googleusercontent.com/fonts/css?kit=vzxKn6nZtIGKCOgTKQG8-3e6S71Rvb7XAk8J16JjOPI);ol{margin:0;padding:0}table td,table th{padding:0}.c6{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:156pt;border-top-color:#000000;border-bottom-style:solid}.c11{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:468pt;border-top-color:#000000;border-bottom-style:solid}.c15{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c4{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Manrope";font-style:normal}.c1{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left;height:11pt}.c9{color:#000000;font-weight:700;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Manrope";font-style:normal}.c2{padding-top:0pt;padding-bottom:0pt;line-height:1.0;text-align:left;height:11pt}.c12{border-spacing:0;border-collapse:collapse;margin-right:auto}.c10{text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;text-decoration:underline}.c8{padding-top:0pt;padding-bottom:0pt;line-height:1.0;text-align:left}.c0{font-weight:400;font-family:"Manrope";font-style:italic}.c14{background-color:#ffffff;max-width:468pt;padding:72pt 72pt 72pt 72pt}.c13{color:inherit;text-decoration:inherit}.c7{font-weight:400;font-family:"Manrope"}.c5{height:21pt}.c3{height:0pt}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Arial"}p{margin:0;color:#000000;font-size:11pt;font-family:"Arial"}h1{padding-top:0pt;color:#000000;font-weight:700;font-size:14pt;padding-bottom:0pt;font-family:"Times New Roman";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h2{padding-top:18pt;color:#000000;font-size:16pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h3{padding-top:16pt;color:#434343;font-size:14pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}</style></head><body class="c14 doc-content"><p class="c1"><span class="c4"></span></p><p class="c1"><span class="c4"></span></p><p class="c1"><span class="c4"></span></p><table class="c12"><tr class="c3"><td class="c6" colspan="1" rowspan="1"><p class="c8"><span class="c9">Where</span></p></td><td class="c6" colspan="1" rowspan="1"><p class="c8"><span class="c9">Who</span></p></td><td class="c6" colspan="1" rowspan="1"><p class="c8"><span class="c9">Concerns (Title)</span></p></td></tr><tr class="c3"><td class="c6" colspan="1" rowspan="1"><p class="c8"><span class="c4">Home &amp; Society</span></p></td><td class="c6" colspan="1" rowspan="1"><p class="c8"><span class="c4">General Public</span></p></td><td class="c6" colspan="1" rowspan="1"><p class="c8"><span class="c4">Unequal Access to Hydrogel-Based Treatments/ Technology</span></p></td></tr><tr class="c5"><td class="c11" colspan="3" rowspan="1"><p class="c8"><span class="c9">Concerns</span></p></td></tr><tr class="c5"><td class="c11" colspan="3" rowspan="1"><p class="c8"><span class="c4">If DNA hydrogel-based systems for therapeutic protein delivery become publicly available, access may be limited by high costs, distribution challenges and geographic disparities. Commercialization often involves proprietary licensing, regulatory overhead, and supply chain mark-ups. As seen in traditional pharmaceutical markets, distributor and retailer margins can drive retail prices far beyond production costs, and similar pricing dynamics could occur with hydrogel-based therapies (Lee et al., 2020). These factors make treatments unaffordable for low-income individuals and under-resourced health systems. Geographic limitations further threaten equitable access. In rural and remote regions, limited infrastructure, high transportation costs, and reduced healthcare coverage can delay the deployment of treatments. If hydrogel therapies require technical instructions, pharmacy-mediated delivery, or monitoring by trained personnel, patients in low-resource areas may face additional barriers. Companies may deprioritize these regions due to lower profit margins, limiting distribution outside urban centers (Lee et al., 2020). Exclusive patents on hydrogel components may restrict local or nonprofit manufacturing. This reduces transparency, increases dependence on single-source suppliers, and makes the technology harder to scale in underserved regions (Lee et al., 2020). Without equity-focused policies, hydrogel-based therapies risk excluding marginalized populations already underserved by healthcare systems. Socioeconomic barriers such as high out-of-pocket costs, limited health literacy, and poor infrastructure can prevent access, particularly in low-income or rural communities (Lee et al., 2020).</span></p></td></tr><tr class="c5"><td class="c11" colspan="3" rowspan="1"><p class="c8"><span class="c9">Potential responses from&hellip;</span></p></td></tr><tr class="c5"><td class="c11" colspan="3" rowspan="1"><p class="c8"><span class="c7">To keep hydrogel-based therapies affordable, governments could work with international health organizations (e.g., WHO, Medicines Patent Pool) and national health ministries to set limits on price m</span><span class="c7">ark-ups</span><span class="c7">&nbsp;and remove taxes for treatments. A hydrogel access and pricing committee of government, researchers, patient advocates, and industry could oversee fair pricing and distribution. Improving delivery to </span><span class="c7">rural</span><span class="c4">&nbsp;and remote communities is also important. Regional hospitals, community clinics, and pharmacies could serve as local pick-up points, with courier or mobile health services delivering to patients&rsquo; homes when needed. Public-private partnerships and targeted subsidies should ensure hydrogel therapies remain affordable and widely available. </span></p></td></tr><tr class="c5"><td class="c11" colspan="3" rowspan="1"><p class="c8"><span class="c9">References (APA)</span></p></td></tr><tr class="c5"><td class="c11" colspan="3" rowspan="1"><p class="c8"><span class="c7">Lee, K. S., Kassab, Y. W., Taha, N. A., &amp; Zainal, Z. A. (2020). Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review. </span><span class="c0">Pharmacy</span><span class="c7">, </span><span class="c0">9</span><span class="c7">(1), 1. </span><span class="c7 c10"><a class="c13" href="https://www.google.com/url?q=https://doi.org/10.3390/pharmacy9010001&amp;sa=D&amp;source=editors&amp;ust=1760080769501690&amp;usg=AOvVaw2-Bh0M6xhHq5r18gsNR--w">https://doi.org/10.3390/pharmacy9010001</a></span><span class="c4">&nbsp;</span></p></td></tr></table><p class="c1"><span class="c15"></span></p></body></html>